Sign in

CIK 0001703057 · Large accelerated filer

AbCellera Biologics Inc.

Sign in to watch
Ticker
ABCL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
British Columbia, Canada
Entity type
operating
Phone
(604) 559-9005
Business address
150 W 4TH AVENUE, VANCOUVER, British Columbia, Canada, V5Y 1G6
  1. 10-Q Report Quarterly Report
  2. 8-K Event Results of operations · Regulation FD disclosure
  3. 424B3 Offering Prospectus
  4. 8-K Event Other events
  5. 424B3 Offering Prospectus
  6. 4 Open-market sale Director sold 100,000 shares at $25.50 ($2,550,000)
  7. 4 Other disposition Director disposed of 5,000,000 shares (other)
  8. 4 Other disposition 10% owner disposed of 5,000,000 shares (other)
  9. 424B3 Offering Prospectus
  10. EFFECT Other Notice of Effectiveness
  11. 8-K Event Shareholder vote results
  12. CORRESP Other Correspondence Between Filers and SEC Staff
  13. 4 Option exercise Chief Operating Officer acquired 333,333 shares (option exercise)
  14. UPLOAD Other SEC-generated Letter
  15. S-1 Offering Registration Statement
  16. 4 Open-market sale 10% owner sold 5,598,420 shares at $24.03 ($134,530,033)
  17. 4 Open-market sale Chief Executive Officer sold 6,000,000 shares at an average $24.13 ($144,770,323)
  18. 4 Open-market sale Chief Operating Officer sold 1,000,000 shares at $25.50 ($25,500,000)
  19. 4 Open-market sale Chief Legal Officer sold 1,000,000 shares at $25.50 ($25,500,000)
  20. 4 Open-market sale Chief Technology Officer sold 1,000,000 shares at $25.50 ($25,500,000)

Page 13 of 17 · 325 filings